CH

Chris Horvath

Chief Commercial Officer, Chief Operating Officer (interim)

AdvanCell Isotopes Pty Ltd

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
AdvanCell Isotopes Pty Ltd
Industry
research
Employees
57.0
Seniority
C suite
Annual Revenue
2000000.0
Total Funding
124398598.0
Latest Funding
Series C

Professional Summary

Chris Horvath serves as Chief Commercial Officer, Chief Operating Officer (interim) at AdvanCell Isotopes Pty Ltd. AdvanCell Isotopes Pty Ltd operates in the research sector with approximately 57.0 employees. The company is headquartered in New York, New York. AdvanCell Isotopes Pty Ltd generates annual revenue of 2000000.0. To date, AdvanCell Isotopes Pty Ltd has raised 124398598.0 in total funding, with the most recent round being Series C.

Industry & Role Insights

  • • MessageCEO tracks 2,961 executives in the research sector.
  • • We have verified contacts for 3 executives at AdvanCell Isotopes Pty Ltd.
  • • 6,952 executive contacts are available in New York.
  • • Our database includes 201,465 c suite-level executives.

Technologies

Outlook Microsoft Office 365 Amazon AWS Vimeo Mobile Friendly reCAPTCHA Remote IoT Basis AI

Keywords

radiopharmaceuticals radioligand discovery 212pb biotechnology biopharmaceuticals changing the course of cancer biotechnology research targeted alpha therapy alpha isotopes prostate cancer cancer treatment quality of life clinical trials isotope supply chain nuclear medicine advanced cancer therapies gmp standards active pharmaceutical ingredient pb generator isotope production therapeutic development clinical development radioligand therapy oncology drug development lead-212 alpha emitters cancer patients scalable solutions pb-advc001 advc002 advc003 pharmaceutical manufacturing nuclear materials science end-to-end solution radiochemical processing innovative therapeutics research & development theranostics molecular imaging companion diagnostics regulatory affairs translational research clinical operations partnership programs cml compliance gmp manufacturing educational partnerships fda requirements preclinical validation safe radiopharmaceutical distribution clinical trial applications therapeutics in oncology health care health wellness & fitness hospital & health care pharmaceuticals medical

Related Executives

AA
Andrew Adamovich Chief Executive Officer at AdvanCell Isotopes Pty Ltd
SP
Simon Puttick Chief Technology Officer at AdvanCell Isotopes Pty Ltd
SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands

Outreach Guidance — research Sector

Executives like Chris Horvath in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at AdvanCell Isotopes Pty Ltd.

Chris Horvath's Position in the MessageCEO Database

  • •Chris Horvath is 1 of 3 verified executive contacts we track at AdvanCell Isotopes Pty Ltd.
  • •2,871 verified executive contacts in research are in the MessageCEO database.
  • •6,778 verified executive contacts in New York are in the database.
  • •16 verified contacts work at research companies in the 57.0 employee range (same size as AdvanCell Isotopes Pty Ltd).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

Frequently Asked Questions

How do I reach Chris Horvath directly?

Chris Horvath's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Commercial Officer, Chief Operating Officer (interim) at AdvanCell Isotopes Pty Ltd. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Chris Horvath work for?

Chris Horvath is Chief Commercial Officer, Chief Operating Officer (interim) at AdvanCell Isotopes Pty Ltd, a company in the research sector with 57.0 employees. The company is based in New York, New York.

Can I pitch or sell to Chris Horvath?

As Chief Commercial Officer, Chief Operating Officer (interim) at AdvanCell Isotopes Pty Ltd, Chris Horvath is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Chris Horvath directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Chris Horvath in?

Chris Horvath works in the research industry as Chief Commercial Officer, Chief Operating Officer (interim) at AdvanCell Isotopes Pty Ltd. MessageCEO provides verified contact information for executives across all major industries.

Is Chris Horvath's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Chris Horvath's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: October 8, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans